Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd.

No trades
No trades

Compare with Santen Pharmaceutical Co., Ltd.


Market capitalization
‪4.04 B‬USD
0.75USD
‪247.92 M‬USD
‪1.94 B‬USD
Beta (1Y)
−0.12

Profile


CEO
Takeshi Ito
Headquarters
Osaka
Founded
1890
IPO date
Nov 4, 1963
ISIN
US80287P1003
CUSIP
80287P100
FIGI
BBG001650570
Identifiers
ISIN US80287P1003
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.